COVID-19

Explore the complexities of COVID-19 research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against COVID-19 with flcube.com.

Bio-Link Capital Completes Strategic Investment in TYK Medicines – Doubling Down on Bispecific, Trispecific and ADC Antibody Platforms
CompanyDeals

Bio-Link Capital Completes Strategic Investment in TYK Medicines – Doubling Down on Bispecific, Trispecific and ADC Antibody Platforms

Bio-Link Capital announced the completion of a strategic investment in TYK Medicines (HKG: 2410), a macromolecule innovative drug company focused on the development of next‑generation antibody therapeutics, including bispecific antibodies,…

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Wuhan YZY Biopharma Files for IPO on Hong Kong Stock Exchange

CompanyMedical Device

NMPA Approves COVID-19 Antigen Detection Reagents from Four Companies

CompanyDrug

Stemirna Therapeutics’ COVID-19 mRNA Vaccine Gets EUA in Laos

CompanyDrug

Fujian Cosunter Completes Enrollment for Phase I Study of GST-HG171

Policy / Regulatory

NMPA Extends Validation Period for COVID-19 Antigen Detection Reagents

CompanyDeals

Frontier Biotechnologies Partners with Yuyue Med for FB2001 Atomizer

CompanyDrug

CSPC and Ascletis Get NMPA Approval for COVID-19 Drug Clinical Trials

CompanyDeals

Westgene Biopharma Secures RMB 150M Series A Financing for mRNA Drug Development

Show More